Nigeria has joined a global initiative aimed at reducing the cost of HIV prevention drugs, making them more accessible to millions of people at risk. The move is part of efforts to curb the spread of HIV and improve public health across the country. The agreement will lower the price of life-saving drugs such as pre-exposure prophylaxis (PrEP), which has been proven to reduce the chances of contracting HIV.

Health experts have welcomed the development, noting that affordability has been a major challenge in the fight against HIV. By cutting costs, more people, especially vulnerable groups, will have access to preventive medication. This is expected to contribute significantly to reducing new HIV infections and supporting Nigeria’s broader public health goals.

The Nigerian government reaffirmed its commitment to global health partnerships and said the new deal would boost efforts to end the HIV epidemic. Officials stressed that prevention remains one of the most effective ways to fight the disease, and reducing drug prices is a key step in saving lives and protecting communities.